Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial

BACKGROUND: Gastric cancer ranks high in terms of morbidity and mortality worldwide. Multimodal therapy is therefore essential for locally advanced gastric cancer. Recent studies have demonstrated that both perioperative chemotherapy and neoadjuvant chemoradiotherapy can improve the prognosis of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jinming, Li, Ning, Tang, Yuan, Jiang, Liming, Yang, Lin, Wang, Shulian, Song, Yongwen, Liu, Yueping, Fang, Hui, Lu, Ningning, Qi, Shunan, Chen, Bo, Li, Ziyu, Liu, Shixin, Wang, Jun, Wang, Wenling, Zhu, Suyu, Yang, Jialin, Li, Yexiong, Zhao, Dongbing, Jin, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331588/
https://www.ncbi.nlm.nih.gov/pubmed/35902798
http://dx.doi.org/10.1186/s12876-022-02440-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331588/
https://www.ncbi.nlm.nih.gov/pubmed/35902798
http://dx.doi.org/10.1186/s12876-022-02440-5

Ejemplares similares